Prolight Diagnostics
0.136
SEK
-4.23 %
PRLD
Nordic SME
Medical Equipment & Services
Health Care
Be the first to follow this company
-4.23%
+1.49%
-2.16%
-11.11%
-17.07%
-53.1%
-86.25%
-93.86%
-68.37%
Prolight Diagnostics develops test systems in POCT (Point of care testing). The tests are used outside of hospital laboratories to enable rapid assessments of the health of patients. The company's POCT platform is under development with the intention of measuring various biomarkers simultaneously. An important component of the work is to reduce the time for test results, particularly important for patients with heart problems. The company was founded in 1999 and is based in Lund.
Read moreMarket cap
95.48M SEK
Turnover
232.65K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
21/2
2025
Annual report '24
14/5
2025
Interim report Q1'25
28/8
2025
Interim report Q2'25
ShowingAll content types
Prolight Diagnostics publicerar investerarbrev för december 2024
Prolight stärker IP-portföljen genom ytterligare patentansökan
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools